TVRDNasdaq CM
Tvardi Therapeutics, Inc.
1.82+2.25%1d
Data as of Aug 25, 2026 · end-of-day snapshot
Volume signal tier—
Alert levelinsufficient_liquidity
Tier and alert level are a summary. Unlock TVRD to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.
−4.21%, downReturn · 1w
−28.35%, downReturn · 1m
−44.85%, downReturn · 3m
−93.77%, downReturn · 1y
−95.83%, well below its 52-week highvs 52-week high
Technicals
Technical readings
The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.
RangeboundSee the full setup read: unlock TVRD
Automated read
The moving-average structure shows no decisive trend in either direction: the mid-term picture reads as rangebound. RSI is currently 39.
RSI (14)39.11, caution readingLower-neutral
MACD / signal-0.19 / -0.22, favorable readingAbove signal line
SMA 502.38, caution readingPrice below
SMA 2003.41, caution readingPrice below
EMA 201.99, caution readingPrice below
ADX (14)12.36Rangebound
+DI / −DI21.09 / 20.71+DI leading
ATR (14)0.13, flagged reading7.1% of price — elevated daily swings
Stochastic %K35.29Mid-range
Bollinger bands (20)1.66 – 2.14Inside bands
ROC (10)2.82, favorable readingPositive over 10 sessions
Trend / momentum impulseMixedTrend and momentum disagree
Readings as of Aug 25, 2026 · end-of-day snapshot
Full analysis
What unlocking TVRD reveals
Sample preview: figures are illustrative.
Company & theme write-up
Signal history
AI narrative
Catalysts & risks
Accumulation read
Unlock
TVRD: full analysis
AI narrative · signals & history · social sentiment · full fundamentals
$9.90 USD
one-time · 30-day access
- Unlocked in about 60 seconds
- 30-day access
- No account needed
Analyzing a few names? Get 5 for $25.00 or 15 for $49.00: one-time, 30 days for the whole pack, swaps included.
Free weekly sample report
Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.
Earnings
When does Tvardi Therapeutics, Inc. report earnings?
Tvardi Therapeutics, Inc. (TVRD) is scheduled to report earnings on Nov 12, 2026.
The date is confirmed rather than estimated, though companies do occasionally reschedule.
Data as of Aug 26, 2026
See who else reports soonNeed the raw data?Get TVRD + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset $9.90one-time Unlock TVRD